RESVINET
  • Home
  • About RSV
    • professionals
    • Publications
  • about us
    • The foundation
    • ReSViNET Team
    • contact us >
      • Support us >
        • Webshop
        • Donate
  • Conference
    • RSVVW'23 >
      • RSVVW'23 Home
      • Registration Fees
      • Visa
      • Accommodation
      • Abstract Submission
      • Young Researchers' Tournament
      • Poster Presentation
      • Accreditation
      • Speakers' Information
    • Previous conferences >
      • RSVVW'21
      • RSVVW'19
      • 4th Meeting 2017
      • 3rd Meeting 2017
      • 2nd Expert Meeting
      • 1st Expert Meeting
  • Webinar Series
  • patient network
    • Activities >
      • Webinars
    • RSV Awareness Week
    • Patient Advisory Board
    • Promise
    • RSV reading material
    • contact patient network
  • Home
  • About RSV
    • professionals
    • Publications
  • about us
    • The foundation
    • ReSViNET Team
    • contact us >
      • Support us >
        • Webshop
        • Donate
  • Conference
    • RSVVW'23 >
      • RSVVW'23 Home
      • Registration Fees
      • Visa
      • Accommodation
      • Abstract Submission
      • Young Researchers' Tournament
      • Poster Presentation
      • Accreditation
      • Speakers' Information
    • Previous conferences >
      • RSVVW'21
      • RSVVW'19
      • 4th Meeting 2017
      • 3rd Meeting 2017
      • 2nd Expert Meeting
      • 1st Expert Meeting
  • Webinar Series
  • patient network
    • Activities >
      • Webinars
    • RSV Awareness Week
    • Patient Advisory Board
    • Promise
    • RSV reading material
    • contact patient network
about resvinet / partners

PARTNERS

ReSViNET is a network that will increase the knowledge for trial design and provide partnership in performing clinical trials, in close collaboration with Julius Clinical as a significant partner offering trial support and expertise. 

​Although ReSViNET was founded by European researchers, the network aims to collaborate with stakeholders outside of Europe, such as investigators from developing countries through RSV GEN led by University of Edinburgh, but also other existing initiatives working on RSV.

​To ensure quality, knowledge and research possibilities, ReSViNET collaborates closely with a range of specialized partners which are listed below:

Learn more

About us
The Foundation
Global Network
Mission and vision
Board Members
ReSViNET Partners

Statutes & ​Policy plan


Foto
Foto
Picture
Julius Clinical is the founding partner of ReSViNET. It is an independent, fast growing academic research organization (ARO), affiliated with the University Medical Center Utrecht, that combines strong scientific leadership, a broad (international) network, and operational excellence to conduct innovative national and clinical global trials.

Julius Clinical's quality standards, innovative trial design and operational metrics are among the best in the industry largely due to their philosophy of continuous process improvements. This has led to enrollment of over 130,000 patients in 55 trials across 30 countries.

The University Medical Center Utrecht is one of the largest public healthcare institution in the Netherlands. With more than 11,000 employees, it is constantly building on the provision of good healthcare services, based on the right people and knowledge.

Healthcare cannot improve without new knowledge about disease and well-being and patients will not receive better healthcare without people who can generate, apply and share this knowledge. UMC Utrecht’s core activities are therefore:

  • To provide state-of-the-art healthcare that requires special knowledge and expertise
  • To carry out cutting-edge scientific research
  • To offer excellent healthcare programs and training to students, doctors, researchers and other healthcare providers

  • STRIDE, a highly interactive and collaborating entity​.
  • Realizing accelerated preclinical and clinical development of drugs, biologicals, vaccines and diagnostics targeting viral infectious diseases.
  • Offering more value to clients by combining expertise into integrated project teams.
  • Covering all R&D activities that will bring novel ideas for RSV intervention strategies.
  • Integrated way bringing basic scientific discoveries, via preclinical and clinical studies to clinical use.

Picture
Picture
Picture
Picture
Picture
Note: All information on ReSViNET is for educational purposes only. For specific medical advice, diagnoses, and treatment, consult your doctor.

© 2021 ReSViNET Foundation. All rights reserved.
About us
Disclosure
Contact